Document 0384
 DOCN  M9490384
 TI    [Kaposi's sarcoma in patients with kidney transplantation]
 DT    9411
 AU    Vlasic-Matas J; Rumboldt Z; Puizina-Ivic N; Luksic B; Milas I; Dubravcic
       M; Forempoher G; Klinika za unutrasnje bolesti Medicinskog fakulteta u
       Zagrebui i; Klinickog bolnickog centra u Splitu.
 SO    Lijec Vjesn. 1994 Mar-Apr;116(3-4):95-7. Unique Identifier : AIDSLINE
       MED/94335518
 AB    An anti-HIV negative patient with cadaveric renal transplant developed
       Kaposi's sarcoma of the skin and gingiva 10 months after
       transplantation, taking triple immunosuppression (cyclosporine,
       azathioprine and prednisone). After reduction of the cyclosporine dose
       and complete cessation of azathioprine administration, the tumor
       regressed without rejection of renal transplant. The patient was a
       carrier of HLA A2 and DR5. When Kaposi's sarcoma was diagnosed serologic
       tests revealed reactivation of cytomegalovirus (CMV) infection. All this
       combined with considerable pharmacological immunosuppression, made the
       patient prone to develop Kaposi's sarcoma, which can regress with
       adequate reduction of immunosuppression.
 DE    Adult  Case Report  English Abstract  Human  Immunosuppression/*ADVERSE
       EFFECTS  Kidney Transplantation/*ADVERSE EFFECTS  Male  Mouth
       Neoplasms/*ETIOLOGY  Sarcoma, Kaposi's/*ETIOLOGY  Skin
       Neoplasms/*ETIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).